A Study of A Novel Approach to Titrate Basal Insulin (LY2963016) in Participants With Type 2 Diabetes

I4L-MC-YCAA -

The main purpose of this study is to evaluate a novel approach for insulin glargine (LY2963016) titration for insulin-naïve adults with type 2 diabetes (T2D).

Trial Summary

Age Range
18 - 80 years
Conditions the trial is for
What the trial is testing?
Could I receive a Placebo?
No
Enrollment Goal
Trial Dates
Aug 16, 2021 - Jun 6, 2022
How long will I be in the trial?
Your participation could last about 24 weeks and may include up to 6 visits to the study center.
Trial Phase
IV

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.